Oracle is behind the AI demand curve, but this could spell accelerating growth and significant upside for investors.
Oracle's stock has plummeted since hitting a high of $345 in September 2025. Will a record quarter quell fears?
Oracle Corporation (NYSE:ORCL) Q3 2026 Earnings Call Transcript March 10, 2026 Oracle Corporation beats earnings expectations. Reported EPS is $1.79, expectations were $1.7. Operator: Hello, and thank ...
Oracle Corporation is rated a Buy due to robust execution, margin inflection, and high potential cloud growth opportunity.
Oracle (ORCL) closed at $141.31 in the latest trading session, marking a -4.57% move from the prior day. The stock's performance was behind the S&P 500's daily loss of 1.04%. Meanwhile, the Dow lost 1 ...
Oracle is making its Health Clinical AI Agent available to NHS trust and private practices. The note-taking software has been piloted at a number of hospital trusts in the UK, including Barts Health ...
LONDON, Feb. 12, 2026 /PRNewswire/ -- Following a successful pilot program at several NHS Trusts, Oracle Health today announced its Clinical AI Agent, Clinical Note is now available in the UK. The new ...
To finance its artificial-intelligence ambitions, Oracle is looking to raise more money at a time when Wall Street has gotten more worried about the level of financing underpinning the AI boom. The ...